DAX22.301 -1,4%Est505.506 -1,1%MSCI World4.343 -0,1%Top 10 Crypto8,9200 -4,1%Nas20.948 -2,2%Bitcoin57.530 +0,1%Euro1,1510 ±0,0%Öl112,6 +6,3%Gold4.508 +2,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 SAP 716460 BASF BASF11 NVIDIA 918422 Siemens Energy ENER6Y Microsoft 870747 CTS Eventim 547030 Lufthansa 823212 Allianz 840400 Novo Nordisk A3EU6F RENK RENK73 Deutsche Telekom 555750 DroneShield A2DMAA Volkswagen (VW) vz. 766403 BYD A0M4W9
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Ölpreise klettern: DAX geht tiefrot ins Wochenende -- Wall Street schließt im Minus -- Bitcoin sackt ab -- BYD-Umsatz stagniert -- CTS Eventim, Rüstungsaktien, NVIDIA, Novo Nordisk, BASF im Fokus
Top News
Cashflow-Rebalancing bei ETFs - steueroptimiert Gewichtung ausgleichen Cashflow-Rebalancing bei ETFs - steueroptimiert Gewichtung ausgleichen
Gold-Rally 2026: Analyst prognostiziert 6.000 US-Dollar bis Jahresende Gold-Rally 2026: Analyst prognostiziert 6.000 US-Dollar bis Jahresende
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Illumina Aktie

Kaufen
Verkaufen
Illumina Aktien-Sparplan
101,96 EUR -6,04 EUR -5,59 %
BMN
101,80 EUR -6,00 EUR -5,57 %
HAML
finanzen.net zero
Illumina jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.15,63 Mrd. EUR

KGV24,77Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN927079

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS4523271090

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolILMN

Illumina Aktien News

DatumMeistgelesen
PR NewswireIllumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026
PR NewswireIllumina Appoints Dr. Eric Green as Chief Medical Officer
PR NewswireIllumina launches powerful software for connected, intuitive, and scalable multiomic analysis
Wer­bungIllumina-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireIllumina To Webcast Upcoming Investor Conference
PR Newswire/C O R R E C T I O N -- MyOme, Inc/
PR NewswireIllumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
PR NewswireIllumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study
PR NewswireIllumina To Webcast Upcoming Investor Conference
PR NewswireIllumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
PR NewswireIllumina Responds to Positive Updates from Chinese Ministry of Commerce
PR NewswireIllumina Reports Financial Results for Third Quarter of Fiscal Year 2025
PR NewswireIllumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
PR NewswireIllumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
PR NewswireIllumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
PR NewswireIllumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
PR NewswireIllumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025
PR NewswireIllumina launches new business to accelerate technology and data-driven discovery
PR NewswireIllumina advances personalized cancer care with new pharma development partnerships
PR NewswireAlnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
PR NewswireIllumina® Protein Prep bringt neue Erkenntnisse aus der Proteomik für eine verbesserte Arzneimittelforschung und -entwicklung
PR NewswireIllumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
PR NewswireIllumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
PR NewswireIllumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
PR NewswireIllumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
PR NewswireNilesh Shah joins Illumina as Head of Region, AMEA
PR NewswireIllumina enhances flagship assay to accelerate access to comprehensive tumor profiling
PR NewswireIllumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025
PR NewswireIllumina named to TIME's World's Most Sustainable Companies list for the second consecutive year
PR NewswireIllumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
PR NewswireIllumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
PR Newswirelllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics
PR NewswireIllumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis
PR NewswireIllumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies
PR NewswireIllumina To Webcast Upcoming Investor Conference
PR NewswireIllumina DRAGEN v4.4 powers clinical oncology research and multiomic applications
PR NewswireIllumina Reports Financial Results for First Quarter of Fiscal Year 2025
PR NewswireIllumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development
PR NewswireIllumina and Tempus partner to drive the future of precision medicine through genomic AI innovation
PR NewswireIllumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025
PR NewswireIllumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors

Illumina News

Illumina News: auf dieser Seite finden Sie alle Illumina News und Nachrichten zur Illumina Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Illumina News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Illumina News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.